Just as importantly, the addition of extra ingredients creates a formulation that differs from the branded products, which compounders may use as a legal justification to avoid producing an outright copy of a brand-name drug.Recall Initiation Date: July 18, 2025Link: FDA Enforcement Report Semaglutide Company: Boothwyn Pharmacy, LLC (licensed compounding pharmacy)Location: Kennett Square, PennsylvaniaScope: Semaglutide, 2.5 mg/mL injection: .8 mL (186 vials), 2 mL (642 vials), 4 mL (648 vials)Drug Description: Treats type 2 diabetes and obesityRecall Reason: Subpotent drugs (which means they less than the specified amount of active ingredient)Recall Initiation Date: July 9, 2025Link: FDA Enforcement Report Semaglutide, Semaglutide/Cyanocobalamin, Tirzepatide, Tirzepatide/Cyanocobalamin Company: Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)Location: Englewood, ColoradoScope: Semaglutide: 5 mg/mL (164 pre-filled syringes)
FDA Advisory Committee Convenes on Peptides This Week, Understanding What Reclassification Mean Why the regulatory shift makes physician oversight and laboratory-guided prescribing more important, not less We are in the interval between the old rule and the new one
Amylin Receptor Biology For example, amylin receptors are formed when the calcitonin receptor associates with receptor activity-modifying proteins, known as RAMPs
It's essential for energy production, DNA repair, and the activation of sirtuins a class of proteins linked to longevity and stress resilience
Early trials have shown promise in non-alcoholic steatohepatitis (NASH), heart failure, and atherosclerosis
